|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.02.26 - 11:36
|
The race for cheaper GLP-1 drugs is hitting legal limits (CNBC)
|
|
|
The push to make weight loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and rising regulatory scrutiny. The dispute centers on pharmaceutical compounding, which is legal for individualized patient needs, and whether it crossed into large-scale marketing. With semaglutide no longer in shortage, Novo says compounded versions are not justified. CNBC's Brandon Gomez reports....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.02.26 - 06:12
|
How leading through discomfort prepared Philips CEO Roy Jakobs for his toughest calls (CNBC)
|
|
|
Roy Jakobs reflects on the early experiences that shaped his leadership—from post‑war lessons in forgiveness to the resilience built through childhood asthma. In "Executive Decisions with Steve Sedgwick," the Philips CEO explains why compassion must sit alongside hard, practical choices—and how those moments of discomfort prepared him to lead the company through its latest evolution....
|
|
|
|
|
|